Clinical trial Recruiting at 1 site Interventional Ages 18 to 45 Women only

Web-based intervention for sexual health in young female cancer survivors

Official title: Assessing the Impact of a Web-based Educational Program on the Sexual Health Outcomes of Young Adult Female Cancer Survivors ~ A Pilot Trial

Run by University of Chicago · NCT06868121 · Data updated 2026-11-12

This study tests whether a web-based program can help young female cancer survivors improve their sexual health and well-being after treatment.

More Sexual Dysfunction trials

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment30 (estimated)
SponsorUniversity of Chicago
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedJanuary 16, 2025
Main results expectedAugust 1, 2026
Study endsNovember 1, 2026
Registry record updatedJune 5, 2026
Trial IDNCT06868121 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are young adult female-bodied individuals aged 18 to 40 who have been diagnosed with cancer and are experiencing sexual dysfunction.

Probably not a fit

Patients currently receiving other investigational agents or those with high infection risks that prevent participation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot trial evaluates the impact of the web-based intervention OMGYES.com on sexual dysfunction among young adult female-bodied cancer survivors aged 18 to 40. Participants will complete online modules at home and attend clinic visits every five weeks to fill out questionnaires. The study aims to assess the feasibility, acceptability, and appropriateness of the intervention by comparing outcomes between those receiving the intervention immediately and those who do not. The trial focuses on individuals who have completed cancer treatment and are in remission.

Why it matters

Potential benefit: If successful, this intervention could significantly improve sexual health and quality of life for young female cancer survivors experiencing sexual dysfunction.

How similar studies have gone: While this specific approach is novel, other studies have explored web-based interventions for sexual health, showing promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 to 45 years
* Diagnosis of cancer between the ages of 15 and 45
* Female genitalia, regardless of gender
* Diagnosed with sexual dysfunction
* Complete Remission and at least two months from a major treatment
* Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial
* Ability to participate in study modules and to respond to surveys
* Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

* Patients receiving other investigational agents
* Patients expected to be neutropenic or have a significantly high infection risk that would exclude them from vaginal penetration
* Patients who are unable complete the study intervention or surveys

Where it's running

  • University of Chicago Hospital
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.